Radioactive stents to reduce restenosis: time for an epitaph?

Inhibitors in Myocardial Ischaemia/Reperfusion. Drugs 1997; 54 (Suppl 5): 31–41. [10] Spargias KS, Lindsay SJ, Hall AS, Cowan JC, Ball SG. Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure. Am J Cardiol 1999; 83: 969–71, A10. [11] Brown NJ, Blais C, Gandhi SK, Adam A. ACE Insertion/ Deletion Genotype Affects Bradykinin Metabolism. J Cardiovasc Pharmacol 1998; 32: 373–7. [12] Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 2000; 102: 829–32. [13] Evans AE, Poirier O, Kee F et al. Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994; 87: 211–4. [14] Marian AJ, Yu QT, Workman R, Greve G, Robert R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 342: 1085–6. [15] Keavney B, McKenzie C, Parish S et al. Large-scale test of hypothesised associations between the angiotensinconverting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 2000; 355 (9202): 434–42.